These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 32618245)

  • 41. Population-wide malaria testing and treatment with rapid diagnostic tests and artemether-lumefantrine in southern Zambia: a community randomized step-wedge control trial design.
    Larsen DA; Bennett A; Silumbe K; Hamainza B; Yukich JO; Keating J; Littrell M; Miller JM; Steketee RW; Eisele TP
    Am J Trop Med Hyg; 2015 May; 92(5):913-921. PubMed ID: 25802434
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Impact of Intermittent Mass Testing and Treatment on Incidence of Malaria Infection in a High Transmission Area of Western Kenya.
    Desai MR; Samuels AM; Odongo W; Williamson J; Odero NA; Otieno K; Shi YP; Kachur SP; Hamel MJ; Kariuki S; Lindblade KA
    Am J Trop Med Hyg; 2020 Jul; 103(1):369-377. PubMed ID: 32342846
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Elimination in South-East Asia? The role of antimalarial drugs].
    Nosten F
    Bull Acad Natl Med; 2016 Mar; 200(3):467-75; discussion 475-6. PubMed ID: 28644000
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effectiveness of reactive focal mass drug administration and reactive focal vector control to reduce malaria transmission in the low malaria-endemic setting of Namibia: a cluster-randomised controlled, open-label, two-by-two factorial design trial.
    Hsiang MS; Ntuku H; Roberts KW; Dufour MK; Whittemore B; Tambo M; McCreesh P; Medzihradsky OF; Prach LM; Siloka G; Siame N; Gueye CS; Schrubbe L; Wu L; Scott V; Tessema S; Greenhouse B; Erlank E; Koekemoer LL; Sturrock HJW; Mwilima A; Katokele S; Uusiku P; Bennett A; Smith JL; Kleinschmidt I; Mumbengegwi D; Gosling R
    Lancet; 2020 Apr; 395(10233):1361-1373. PubMed ID: 32334702
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Artemisinin-based combination therapy in pregnant women in Zambia: efficacy, safety and risk of recurrent malaria.
    Nambozi M; Kabuya JB; Hachizovu S; Mwakazanga D; Mulenga J; Kasongo W; Buyze J; Mulenga M; Van Geertruyden JP; D'Alessandro U
    Malar J; 2017 May; 16(1):199. PubMed ID: 28511713
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mass drug administration for the control and elimination of Plasmodium vivax malaria: an ecological study from Jiangsu province, China.
    Hsiang MS; Hwang J; Tao AR; Liu Y; Bennett A; Shanks GD; Cao J; Kachur SP; Feachem RG; Gosling RD; Gao Q
    Malar J; 2013 Nov; 12():383. PubMed ID: 24175930
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The Gametocytocidal Efficacy of Different Single Doses of Primaquine with Dihydroartemisinin-piperaquine in Asymptomatic Parasite Carriers in The Gambia: A Randomized Controlled Trial.
    Okebe J; Bousema T; Affara M; Di Tanna GL; Dabira E; Gaye A; Sanya-Isijola F; Badji H; Correa S; Nwakanma D; Van Geertruyden JP; Drakeley C; D'Alessandro U
    EBioMedicine; 2016 Nov; 13():348-355. PubMed ID: 27825738
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dihydroartemisinin-piperaquine for intermittent preventive treatment of malaria during pregnancy and risk of malaria in early childhood: A randomized controlled trial.
    Jagannathan P; Kakuru A; Okiring J; Muhindo MK; Natureeba P; Nakalembe M; Opira B; Olwoch P; Nankya F; Ssewanyana I; Tetteh K; Drakeley C; Beeson J; Reiling L; Clark TD; Rodriguez-Barraquer I; Greenhouse B; Wallender E; Aweeka F; Prahl M; Charlebois ED; Feeney ME; Havlir DV; Kamya MR; Dorsey G
    PLoS Med; 2018 Jul; 15(7):e1002606. PubMed ID: 30016328
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Primaquine or other 8-aminoquinoline for reducing P. falciparum transmission.
    Graves PM; Gelband H; Garner P
    Cochrane Database Syst Rev; 2014 Jun; (6):CD008152. PubMed ID: 24979199
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Study protocol for a cluster randomised controlled factorial design trial to assess the effectiveness and feasibility of reactive focal mass drug administration and vector control to reduce malaria transmission in the low endemic setting of Namibia.
    Medzihradsky OF; Kleinschmidt I; Mumbengegwi D; Roberts KW; McCreesh P; Dufour MK; Uusiku P; Katokele S; Bennett A; Smith J; Sturrock H; Prach LM; Ntuku H; Tambo M; Didier B; Greenhouse B; Gani Z; Aerts A; Gosling R; Hsiang MS
    BMJ Open; 2018 Jan; 8(1):e019294. PubMed ID: 29374672
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Efficacy of dihydroartemisinin-piperaquine versus artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria among children in Africa: a systematic review and meta-analysis of randomized control trials.
    Assefa DG; Yismaw G; Makonnen E
    Malar J; 2021 Aug; 20(1):340. PubMed ID: 34384431
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Paediatric formulations of artemisinin-based combination therapies for treating uncomplicated malaria in children.
    Bélard S; Ramharter M; Kurth F
    Cochrane Database Syst Rev; 2020 Dec; 12(12):CD009568. PubMed ID: 33289099
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Primaquine or other 8-aminoquinoline for reducing Plasmodium falciparum transmission.
    Graves PM; Gelband H; Garner P
    Cochrane Database Syst Rev; 2015 Feb; (2):CD008152. PubMed ID: 25693791
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Distribution of Plasmodium species and assessment of performance of diagnostic tools used during a malaria survey in Southern and Western Provinces of Zambia.
    Sitali L; Miller JM; Mwenda MC; Bridges DJ; Hawela MB; Hamainza B; Chizema-Kawesha E; Eisele TP; Chipeta J; Lindtjørn B
    Malar J; 2019 Apr; 18(1):130. PubMed ID: 30971231
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A phase III, randomized, non-inferiority trial to assess the efficacy and safety of dihydroartemisinin-piperaquine in comparison with artesunate-mefloquine in patients with uncomplicated Plasmodium falciparum malaria in southern Laos.
    Mayxay M; Keomany S; Khanthavong M; Souvannasing P; Stepniewska K; Khomthilath T; Keola S; Pongvongsa T; Phompida S; Ubben D; Valecha N; White NJ; Newton PN
    Am J Trop Med Hyg; 2010 Dec; 83(6):1221-9. PubMed ID: 21118925
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Efficacy of two versus three-day regimens of dihydroartemisinin-piperaquine for uncomplicated malaria in military personnel in northern Cambodia: an open-label randomized trial.
    Lon C; Manning JE; Vanachayangkul P; So M; Sea D; Se Y; Gosi P; Lanteri C; Chaorattanakawee S; Sriwichai S; Chann S; Kuntawunginn W; Buathong N; Nou S; Walsh DS; Tyner SD; Juliano JJ; Lin J; Spring M; Bethell D; Kaewkungwal J; Tang D; Chuor CM; Satharath P; Saunders D
    PLoS One; 2014; 9(3):e93138. PubMed ID: 24667662
    [TBL] [Abstract][Full Text] [Related]  

  • 57. In vivo/ex vivo efficacy of artemether-lumefantrine and artesunate-amodiaquine as first-line treatment for uncomplicated falciparum malaria in children: an open label randomized controlled trial in Burkina Faso.
    Lingani M; Bonkian LN; Yerbanga I; Kazienga A; Valéa I; Sorgho H; Ouédraogo JB; Mens PF; Schallig HDFH; Ravinetto R; d'Alessandro U; Tinto H
    Malar J; 2020 Jan; 19(1):8. PubMed ID: 31906948
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Safety and efficacy of dihydroartemisinin-piperaquine versus artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Zambian children.
    Nambozi M; Van Geertruyden JP; Hachizovu S; Chaponda M; Mukwamataba D; Mulenga M; Ubben D; D'Alessandro U
    Malar J; 2011 Feb; 10():50. PubMed ID: 21352609
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Impact of retreatment with an artemisinin-based combination on malaria incidence and its potential selection of resistant strains: study protocol for a randomized controlled clinical trial.
    Muhindo Mavoko H; Nabasumba C; Tinto H; D'Alessandro U; Grobusch MP; Lutumba P; Van Geertruyden JP
    Trials; 2013 Sep; 14():307. PubMed ID: 24059911
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A Phase 3, Double-Blind, Randomized Study of Arterolane Maleate-Piperaquine Phosphate vs Artemether-Lumefantrine for Falciparum Malaria in Adolescent and Adult Patients in Asia and Africa.
    Toure OA; Valecha N; Tshefu AK; Thompson R; Krudsood S; Gaye O; Rao BHK; Sagara I; Bose TK; Mohanty S; Rao BS; Anvikar AR; Mwapasa V; Noedl H; Arora S; Roy A; Iyer SS; Sharma P; Saha N; Jalali RK; ; Tiacoh L; Enosse S; Tangpukdee N; Kokolomami J; Ndiaye JL; Rao D; Yumva NN; Sidibe B; Mohanty R; Jha AC; Nyirenda M; Starzengruber P; Swoboda P
    Clin Infect Dis; 2016 Apr; 62(8):964-971. PubMed ID: 26908796
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.